218 related articles for article (PubMed ID: 8871612)
1. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41.
Peterson M; Miller J
Nature; 1992 Jun; 357(6379):596-8. PubMed ID: 1608470
[TBL] [Abstract][Full Text] [Related]
3. The p41 isoform of invariant chain is a chaperone for cathepsin L.
Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
5. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
[TBL] [Abstract][Full Text] [Related]
6. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
Stebbins CC; Peterson ME; Suh WM; Sant AJ
J Immunol; 1996 Dec; 157(11):4892-8. PubMed ID: 8943393
[TBL] [Abstract][Full Text] [Related]
7. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
[TBL] [Abstract][Full Text] [Related]
8. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
Swier K; Miller J
J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
Mihelic M; Dobersek A; Guncar G; Turk D
J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
[TBL] [Abstract][Full Text] [Related]
10. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
11. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
12. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms.
Bikoff EK; Kenty G; Van Kaer L
J Immunol; 1998 Apr; 160(7):3101-10. PubMed ID: 9531264
[TBL] [Abstract][Full Text] [Related]
13. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
Bertolino P; Staschewski M; Trescol-Biémont MC; Freisewinkel IM; Schenck K; Chrétien I; Forquet F; Gerlier D; Rabourdin-Combe C; Koch N
J Immunol; 1995 Jun; 154(11):5620-9. PubMed ID: 7751615
[TBL] [Abstract][Full Text] [Related]
14. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
15. Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue.
Zavasnik-Bergant V; Sekirnik A; Golouh R; Turk V; Kos J
Biol Chem; 2001 May; 382(5):799-804. PubMed ID: 11517933
[TBL] [Abstract][Full Text] [Related]
16. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
Bertolino P; Rabourdin-Combe C
Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
[TBL] [Abstract][Full Text] [Related]
18. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.
Fineschi B; Arneson LS; Naujokas MF; Miller J
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10257-61. PubMed ID: 7479763
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
